Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
o Brijesh Madhok<br />
University of Leeds, UK<br />
Inhibition of pyruvate dehydrogenase kinase activity promotes<br />
apoptosis in colorectal cancer cells<br />
o Sashidar Yeluri<br />
Leeds Institute of Molecular Medicine, University of Leeds & St James’s<br />
University Hospital, UK<br />
Lactase dehydrogenase-5 is an independent prognostic factor in<br />
colorectal cancer: implication for future therapies<br />
Improving patient care: quality assurance of psychological care<br />
Hosted by Michael Sharpe<br />
University of Edinburgh, UK<br />
o Michael Sharpe<br />
University of Edinburgh, UK<br />
Introduction<br />
o Jane Walker<br />
University of Edinburgh, UK<br />
SMaRT quality assurance: making sure the treatment given is the<br />
treatment intended<br />
o Amanda Ramirez<br />
Guy’s, King’s and St Thomas’ School of Medicine, London, UK<br />
Maintaining the quality of a complex behavioural intervention to<br />
promote early presentation of cancer in a randomised controlled<br />
trial<br />
o John Norrie<br />
Robertson Centre for Biostatistics, University of Glasgow, UK<br />
‘Quality’ issues in complex intervention randomised controlled<br />
trials<br />
Proffered paper presentations:<br />
o Caroline Burgess<br />
Institute of Psychiatry/King’s College London, London, UK<br />
Training health professionals to deliver an intervention to promote<br />
early presentation of breast cancer: a pilot study in the NHS<br />
Breast Screening <strong>Programme</strong><br />
o Eleanor Mann<br />
Kings College London, UK<br />
Cognitive behaviour therapy for menopausal symptoms following<br />
breast cancer treatment<br />
o Galina Velikova<br />
University of Leeds, UK<br />
Patients report improvements in continuity of care when quality of<br />
life assessments are used routinely in oncology practice:<br />
secondary outcomes of a randomised controlled trial<br />
13